Validation of Novaprep(®) HQ+ liquid-based cytology medium for high-risk human papillomavirus detection by hc2.

Fiche publication

Date publication

janvier 2016

Journal

Infectious agents and cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PRETET Jean-Luc , Dr LAUNAY Sophie

Tous les auteurs :
Guenat D, Launay S, Riethmuller D, Mougin C, Prétet JL

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27536333

Résumé

Preanalytical conditions determine the reliability and validity of bioassays. Therefore, the analytic performances of biological tests need to be determined when preanalytical steps differ from those recommended by the manufacturer. The objective of the study was to assess the analytic performance of the hc2 test for the detection of high-risk HPV DNA from cells stored in the new Novaprep® HQ+ medium.